The Role of SGLT-2 Inhibitors as Part of Optimal Medical Therapy in Improving Cardiovascular Outcomes in Patients with Diabetes and Coronary Artery Disease.

Mosleh, Wassim; Sharma, Abhinav; Sidhu, Mandeep S; Page, Brian; Sharma, Umesh C; Farkouh, Michael E

Mosleh, Wassim; Sharma, Abhinav; Sidhu, Mandeep S; Page, Brian; Sharma, Umesh C; Farkouh, Michael E.

Afiliação

Mosleh W; University at Buffalo, State University of New York, Buffalo, NY, USA.
Sharma A; Duke Clinical Research Institute, Duke University, Durham, NC, USA.
Sidhu MS; Department of Medicine, Albany Medical College, Albany Medical Center, Albany, NY, USA.
Page B; University at Buffalo, State University of New York, Buffalo, NY, USA.
Sharma UC; University at Buffalo, State University of New York, Buffalo, NY, USA.
Farkouh ME; Peter Munk Cardiac Centre, University Health Network, 585 University Avenue, 4N474, Toronto, ON, M5G 2N2, Canada. michael.farkouh@uhn.ca.

Cardiovasc Drugs Ther ; 31(3): 311-318, 2017 Jun.

Article em En | MEDLINE | ID: mdl-28536852

Assuntos

Doenças Cardiovasculares/prevenção & controle; Sistema Cardiovascular/efeitos dos fármacos; Doença da Artéria Coronariana/tratamento farmacológico; Inibidores do Transportador 2 de Sódio-Glicose; Animais; Diabetes Mellitus Tipo 2; Humanos

Palavras-chave

Coronary artery disease; Diabetes mellitus; Optimal medical therapy; Outcomes; SGLT2 inhibitors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Doenças Cardiovasculares / Sistema Cardiovascular / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Guideline Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google